Agudelo · Cell 2014 · Preclinical animal and mechanistic study · n=?

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.

Cited 746 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical animal and mechanistic study with transgenic mouse models and no clinical trial data in abstract

PubMed 25259918 · doi:10.1016/j.cell.2014.07.051 · record verified 2026-08-30

What was done

The authors investigated the biological mechanism connecting exercise to resilience against depression using mouse models. They examined how exercise training and skeletal muscle PGC-1α1 alter kynurenine metabolism through the PGC-1α1-PPARα/δ pathway, evaluating behavioral resistance to chronic mild stress or direct kynurenine administration in skeletal muscle-specific PGC-1α1 transgenic mice.

What was found

Activation of the PGC-1α1-PPARα/δ pathway increased skeletal muscle expression of kynurenine aminotransferases, converting circulating kynurenine into kynurenic acid, an end product unable to cross the blood-brain barrier. Reducing plasma kynurenine protected the brain from stress-induced depressive changes and rendered transgenic mice resistant to depression induced by chronic mild stress or direct kynurenine administration. The abstract reports no quantitative values, sample sizes, or effect sizes.

Why it matters

This study demonstrates a peripheral mechanism whereby muscle remodeling from exercise protects the central nervous system against depression-like pathology. It highlights therapeutic potential for depression by targeting skeletal muscle metabolism without requiring drugs to cross the blood-brain barrier.

Limits

The findings are derived entirely from animal models, and no sample sizes or numerical effect sizes are provided in the abstract. Whether this peripheral mechanism translates directly to human major depressive disorder was not evaluated.

Cited by